This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
We would like to draw attention to a discrepancy in the lead summary of our article, "Central Nervous System and Cardiovascular Effects of Rauwolfia Serpentina," that appeared in the Feb. 25, 1956, issue of The Journal, page 622. This summary was not prepared by us, nor did we have the opportunity to review it prior to publication. The major point in question is the statement in the summary that "in 15 patients with angina pectoris the alseroxylon seemed to be no more effective than the placebo preparation." Our findings, as presented in the text of the article, were quite to the contrary. In the second paragraph on page 626 we stated that "12 of the 15 subjects had improved with therapy." Table 2 on the same page illustrates in more detail the therapeutic responses of these 15 subjects. Furthermore, in the addendum on page 628, we pointed
Lewis BI, Lubin RI, January LE, Wild JB. EFFECTS OF RAUWOLFIA SERPENTINA. JAMA. 1956;161(2):177. doi:10.1001/jama.1956.02970020057024
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: